Sign in
4/A

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000950170-25-042724

Chief Technology Officer sold 31,278 shares at $8.82 ($275,947)

  • Chief Technology Officer acquired 20,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Tyagarajan Seshu Chief Technology Officer 2025-03-17 Option exercise 10b5-1 +20,000 $1.29 $25,800 116,790 D: show line 1 in the form
Tyagarajan Seshu Chief Technology Officer 2025-03-17 Sale 10b5-1 −31,278 $8.82 $275,947 85,512 D: show line 2 in the form
Open-market sales · 31,278 sh · avg $8.82 · $275,947

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Tyagarajan Seshu Chief Technology Officer 2025-03-17 Option exercise · Stock Option (Right to Buy) 10b5-1 −20,000 70,000 D: show line 3 in the form
Loading xslF345X05/ownership.xml…